tradingkey.logo
tradingkey.logo
Search

Avanos Medical Inc

AVNS
Add to Watchlist
24.990USD
+0.010+0.04%
Close 07-24 16:00ETQuotes delayed by 15 min
1.17BMarket Cap
LossP/E TTM

Earnings Forecast

Currency: USD Updated: 2026-07-24
Previous score
6.00
Change
0
The current earnings forecast score of Avanos Medical Inc is 6.00, ranking 174 out of 200 in the Healthcare Equipment & Supplies industry. The average price target is 14.00, with a high of 14.00 and a low of 14.00.

Analyst Rating

Based on 1 analysts
Hold
Current Rating
14.000
Target Price
+13.73%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

109
Total
7
Median
9
Average
Company name
Ratings
Analysts
Avanos Medical Inc
AVNS
1
Medtronic PLC
MDT
34
Dexcom Inc
DXCM
32
Zimmer Biomet Holdings Inc
ZBH
31
Stryker Corp
SYK
31
Abbott Laboratories
ABT
31
1
2
3
...
22

Support & Resistance

Relevant data have not been disclosed by the company yet.

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Forecast
Actual

FAQs

What is Avanos Medical Inc's expected revenue for the next quarter?

Avanos Medical Inc's expected revenue is 173.00M.

What is Avanos Medical Inc's price target?

Analysts forecast that Avanos Medical Inc's price target is USD 14.00, with the highest forecast at USD 14.00 and the lowest forecast at USD 14.00.

How have Avanos Medical IncAVNS's recent earnings per share performed?

The market expectation was USD 0.11, while Avanos Medical IncAVNS's earnings per share (EPS) for the previous quarter was USD -0.03. EPS for the next quarter is expected at USD 0.16.

What is the analyst rating for Avanos Medical Inc?

Based on the ratings of Avanos Medical Inc's stock from 1 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.